GW Phar­ma cannabi­noid to be test­ed for Alzheimer's ag­i­ta­tion; Acor­da rev­enue plum­mets as gener­ics evis­cer­ate its fran­chise

→ Alzheimer’s Re­search UK is fund­ing a study at King’s Col­lege us­ing GW Phar­ma’s re­cent­ly ap­proved cannabi­noid drug Sativex in de­men­tia. The study will …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.